NCT07358806 Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07355504 Prostate Cancer Early Detection Using Serial MRI Examinations Status NOT_YET_RECRUITING Phase NA
NCT07354919 Axelopran for Advanced Cancer in Patients Receiving Opioids Status RECRUITING Phase PHASE2
NCT07351461 Anxiety in Patients Under Active Surveillance for Localized Prostate Cancer and Their Partners. Status RECRUITING Phase N/A
NCT07344363 Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoring Status RECRUITING Phase N/A
NCT07339267 A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer Status RECRUITING Phase PHASE1
NCT07336446 A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs Status RECRUITING Phase PHASE1/PHASE2
NCT07335796 A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer Status RECRUITING Phase PHASE2
NCT07333807 Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy Status COMPLETED Phase NA
NCT07328516 Natural History Study of Early Life Exposures in Agriculture (ELEA) Status ENROLLING_BY_INVITATION Phase N/A
NCT07325721 Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer Status RECRUITING Phase PHASE2
NCT07319923 Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing Status RECRUITING Phase N/A
NCT07318051 Sample Collection for Ongoing Research and Product Evaluation Study Status RECRUITING Phase N/A
NCT07313241 Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER) Status RECRUITING Phase PHASE2
NCT07311915 Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study Status NOT_YET_RECRUITING Phase NA